We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

2 hedge funds and large institutions have $19.7K invested in ENZON PHARMACEUTICALS INC in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 42 (-2)

53% less capital invested

Capital invested by funds: $41.7K → $19.7K (-$22K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$19K
CFA
2
CT Financial Advisors
Pennsylvania
$730
Tudor Investment Corp
3
Tudor Investment Corp
Connecticut
-$18K -47,998 Closed
MCM
4
Monarch Capital Management
Indiana
-$4K -10,000 Closed

ENZN Hedge Fund Activity: Q4 2016 in Review

2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q4 2016, worth a combined $19.7K — down 53% from $41.7K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ENZN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tudor Investment Corp, exiting entirely with an estimated $18K sold.

  • 2 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q4 2016, down from 4 in Q3 2016.
  • Funds reported $19.7K of ENZON PHARMACEUTICALS INC stock for Q4 2016, down 53% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q4 2016 and 2 closed out, a net change of -2 holders.
  • The largest ENZON PHARMACEUTICALS INC seller in Q4 2016 was Tudor Investment Corp, an estimated $18K sold.

Based on aggregated 13F filings for Q4 2016.